A new study published in The Lancet Infectious Diseases this week has found that metformin, a drug commonly used to treat diabetes, reduces the risk of long COVID.
Related Articles
Sierra Space Taps Global Authority on Expandable Space Station Technology for Key Leadership Role
LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading commercial space-tech company and next generation defense-tech prime building a platform in space to benefit life on Earth, announced today the promotion of Shawn Buckley to Vice President of […]
Rebalance Health Launches Groundbreaking Products with Proven Clinical Efficacy in Relieving Hot Flashes, Anxiety, and Boosting Testosterone
BOULDER, Colo., May 9, 2023 /PRNewswire/ — Rebalance Health, Inc. (www.rebalancehealth.com), the health and wellness innovators that specialize in optimizing human wellness through cortisol management, have launched three new “Superceutical™” systems, high-potency natural supplements… Click […]
Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells
Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced today the Seattle Children’s activation of the Phase 1 ENLIGHTen clinical trial in […]
